Venclexta (venetoclax)

pCPA File Number: 21375
Negotiation Status:
Active Negotiation
Indication(s):
In combination with obinutuzumab for the treatment of Chronic Lymphocytic Leukemia
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
PC0212-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable